| 000 | 01794 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516003658.0 | ||
| 264 | 0 | _c20110201 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1440-1797 | ||
| 024 | 7 |
_a10.1111/j.1440-1797.2010.01302.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aValladares-Salgado, Adán | |
| 245 | 0 | 0 |
_aAssociation of polymorphisms within the transforming growth factor-β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. _h[electronic resource] |
| 260 |
_bNephrology (Carlton, Vic.) _cSep 2010 |
||
| 300 |
_a644-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xblood |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMexico |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xgenetics |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aAngeles-Martínez, Javier | |
| 700 | 1 | _aRosas, Marisol | |
| 700 | 1 | _aGarcía-Mena, Jaime | |
| 700 | 1 | _aUtrera-Barillas, Dolores | |
| 700 | 1 | _aGómez-Díaz, Rita | |
| 700 | 1 | _aEscobedo-de la Peña, Jorge | |
| 700 | 1 | _aParra, Esteban J | |
| 700 | 1 | _aCruz, Miguel | |
| 773 | 0 |
_tNephrology (Carlton, Vic.) _gvol. 15 _gno. 6 _gp. 644-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1797.2010.01302.x _zAvailable from publisher's website |
| 999 |
_c20211535 _d20211535 |
||